Accession Number : ADA194461


Title :   AFRRI (Armed Forces Radiobiology Research Institute) Reports, October, November and December 1987.


Descriptive Note : Technical rept.


Corporate Author : ARMED FORCES RADIOBIOLOGY RESEARCH INST BETHESDA MD


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/a194461.pdf


Report Date : Mar 1988


Pagination or Media Count : 207


Abstract : Partial Contents: The mast cell granule: A phospholipid source for prostaglandin synthesis; Research issues for radiation protection for man during prolonged spaceflight; Quantification of gut injury with diamine oxidase activity; Development of a fission neutron RBE and measurements with combined injury in mouse models; Rat monocytes in a model of combined injury express the OX8 antigen; Involvement of histamine H1 and H2 receptors in hypothermia induced by ionizing radiation in guinea pigs; Locomotor behavior in mice following exposure to fission-neutron irradiation and trauma; Alterations in locomotor activity induced by radioprotective doses of 16,16-dimethyl prostaglandin E2; Fetal hypothalamic brain grafts reduce the obesity produced by ventromedial hypothalamic lesions; The rhesus monkey: A primate model for hemopoietic stem cell studies; Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor; Radiation-induced hematologic and nonspecific immunologic effects in the canine.


Descriptors :   *RADIATION PROTECTION , *SPACE FLIGHT , *RADIATION EFFECTS , *RADIOPROTECTIVE AGENTS , DIAMINE OXIDASE , DOSAGE , FISSION NEUTRONS , GUINEA PIGS , HYPOTHERMIA , IONIZING RADIATION , MICE , MILITARY RESEARCH , MODELS , MONOCYTES , NECROSIS , NEOPLASMS , OBESITY , PHOSPHOLIPIDS , PRIMATES , PROSTAGLANDIN , RADIOBIOLOGY , RADIOPROTECTIVE AGENTS , RATS , RHESUS MONKEYS , SOURCES , SYNTHESIS , TRAUMA , WOUNDS AND INJURIES


Subject Categories : Astronautics
      Radiobiology
      Pharmacology


Distribution Statement : APPROVED FOR PUBLIC RELEASE